Delivery Order SPE2DB24D1034-SPE2DB25FWBL3
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,271.31, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 19, 2024. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,302.11, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. This award is not designated under any set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,667.40, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of February 20, 2025. The contract is not associated with a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,947.90, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of November 22, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,629.90, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of March 12, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,557.06, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. This award is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,408.02, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract has an ultimate completion date of March 28, 2025 and is a firm fixed-price delivery order. This contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,664.34, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has a ceiling value of $17,967.64 and runs through March 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,189.96, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The contract has a completion date of February 25, 2025 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite...